Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Highly scalable and cost-effective developer of monoclonal antibodies for the drug discovery application.Funding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Northern Light Venture Capital Ltd | China-focused venture capital firm targeting early and early growth stage TMT, advanced technology and healthcare opportunities. | China |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Northern Light Venture Capital Ltd China-focused venture capital firm targeting early and early growth stage TMT, advanced technology and healthcare opportunities. |
+1 (650) 585-5450 |
N/A |